Chemoinformaics analysis of 2,4,6-Trihydroxy-3-methyl-5-(3-methylbutanoyl)benzaldehyde
| Molecular Weight | 252.266 | nRot | 4 |
| Heavy Atom Molecular Weight | 236.138 | nRig | 8 |
| Exact Molecular Weight | 252.1 | nRing | 1 |
| Solubility: LogS | -3.765 | nHRing | 0 |
| Solubility: LogP | 4.007 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 36.3887 |
| nHD | 3 | BPOL | 17.7873 |
| QED | 0.563 |
| Synth | 2.832 |
| Natural Product Likeliness | 1.548 |
| NR-PPAR-gamma | 0.873 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.018 |
| CACO-2 | -4.872 |
| MDCK | 0.000012 |
| BBB | 0.032 |
| PPB | 0.980947 |
| VDSS | 0.846 |
| FU | 0.0166201 |
| CYP1A2-inh | 0.657 |
| CYP1A2-sub | 0.116 |
| CYP2c19-inh | 0.083 |
| CYP2c19-sub | 0.162 |
| CYP2c9-inh | 0.331 |
| CYP2c9-sub | 0.772 |
| CYP2d6-inh | 0.112 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.154 |
| CYP3a4-sub | 0.122 |
| CL | 5.33 |
| T12 | 0.48 |
| hERG | 0.004 |
| Ames | 0.373 |
| ROA | 0.059 |
| SkinSen | 0.869 |
| Carcinogencity | 0.247 |
| EI | 0.916 |
| Respiratory | 0.686 |
| NR-Aromatase | 0.099 |
| Antiviral | Yes |
| Prediction | 0.710107 |